Connect with us

Hi, what are you looking for?

Stock

Exxon Mobil, Tesla lead Monday’s market cap stock movers

Monday’s market has seen significant movements across various stocks, with market participants reacting to news and shifting sentiments. Mega-cap stocks like Exxon Mobil (NYSE:XOM) have experienced gains, while Tesla Motors (NASDAQ:TSLA) has seen a decline. In the large-cap arena, Constellation Energy Group-Exch (CEG) faced a notable drop, whereas Yum China Holdings Inc (NYSE:YUMC) surged on strong earnings. Here are the intra-day stock movers within the mega-cap and large-cap categories.

Mega-Cap Movers:

Exxon Mobil (XOM); gains on oil rebound; +3.07%
Tesla Motors (TSLA); China-made EV sales fall 5.3%; -1.5%
Wells Fargo (WFC); banks stocks weaker ahead of election/Fed; -2.2%

Large-Cap Stock Movers:

Constellation Energy Group (CEG); falls following earnings; -10.03%
Yum China Holdings Inc (YUMC); Yum China stock jumps on earnings beat, strong sales growth; +8.7%
Chewy Inc (NYSE:CHWY); added to S&P 400 +8.98%
Vistra Energy Corp (NYSE:VST); -2.75%
Xpeng Inc (NYSE:XPEV); +5.38%
Ctrip.com International (TCOM); +4.65%
Floor Decor Holdings (FND); +5.46%
Sherwin Williams (SHW); +4.43%

Mid-Cap Stock Movers:

Chemours Co (CC); Chemours stock rises as Q3 earnings and revenue top estimates; +16.33%
TG Therapeutics Inc (NASDAQ:TGTX); FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics; -10.82%
DigitalOcean Holdings (DOCN); -11.36%
Knife River (KNF); Knife River stock up 2% as Q3 revenue hits record, guidance narrowed; -9.79%
Affiliated Managers Group Inc (NYSE:AMG); AMG reports lower Q3 earnings as assets under management decline; -8.08%
Israel Chemicals Ltd (ICL); +8.19%
Sunrun Inc (NASDAQ:RUN); +9.55%

Small-Cap Stock Movers:

Aquinox Pha (NGNE); Neurogene secures $200 million in oversubscribed PIPE financing; +36.23%
Air Transport Service (ATSG); Stonepeak nears $3.1 billion deal for aircraft lessor ATSG (ATSG) – Reuters (earlier); +26.24%
Fs Development Corp (IRON); FDA aligns with Disc Medicine on EPP treatment study; +19.57%
Integra LifeScien (IART); +25.47%
Hamilton Beach A (HBB); -18.67%
Uxin (NASDAQ:UXIN); +8.84%
BioCryst Pharmaceuticals (NASDAQ:BCRX); -16.43%
Airsculpt Technologies (AIRS); +15.19%
Third Harmonic (NASDAQ:HLIT) Bio (THRD); -15.63%
NAPCO Security Te (NSSC); -11.89%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    Economy

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com